Banner
Drug Manufacturers – Major

Abbott Laboratories, Inc. (NYSE: ABT) – FYE 12/2020 – REDUCE – The stock is currently trading at levels at or above my most recent $97 reduce target, but below my most recent $124 terminate target. Please See Linked PDF Worksheet.
Revised on 05/31/2021

AbbVie, Inc. (Nasdaq: ABBV) – FYE 12/2020 – FAIRLY VALUED – The stock is currently trading at levels above my most recent $77 initiate target, but below my most recent $138 reduce target. Please See Linked PDF Worksheet.
Revised on 09/17/2021

Bristol Meyers Squibb Company, Inc. (NYSE: BMY) – FYE 12/2020 – FAIRLY VALUED – The stock is currently trading at levels above my most recent $36 initiate target, but below my most recent $63 reduce target. Please See Linked PDF Worksheet.
Revised on 02/22/2021

Johnson and Johnson (NYSE: JNJ) – FYE 12/2020 – FAIRLY VALUED – The stock is currently trading at levels above my most recent $113 initiate target, but below my most recent $202 reduce target. Please See Linked PDF Worksheet.
Revised on 09/19/2021

Omeros Corporation (Nasdaq: OMER) – FYE 12/2019 – OVER VALUED – The stock is currently trading at levels above my most recent $(12) terminate target. Please See Linked PDF Worksheet.
Revised on 01/18/2021

Please note that worksheets are updated basis the most current SEC 10-K ANNUAL filing.